SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-004147
Filing Date
2015-04-30
Accepted
2015-04-30 06:07:09
Documents
9
Period of Report
2015-06-26
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224398zdef14a.htm DEF 14A 1098623
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G790710.JPG g790710.jpg GRAPHIC 58945
5 G190718.JPG g190718.jpg GRAPHIC 43409
6 G311669.JPG g311669.jpg GRAPHIC 27597
7 G496695.JPG g496695.jpg GRAPHIC 51704
8 G96092BII001.GIF g96092bii001.gif GRAPHIC 57428
9 G96092BII002.GIF g96092bii002.gif GRAPHIC 52867
  Complete submission text file 0001047469-15-004147.txt   1535904
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 15814974
SIC: 2834 Pharmaceutical Preparations